Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
Study NCT ID:
NCT05219669
Status:
COMPLETED
Last Update Posted:
2024-08-05
First Post:
2022-01-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
Sponsor:
Opiant Pharmaceuticals Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-21
First Submit QC Date:
None
Study First Post Date:
2022-02-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-19
Results First Submit QC Date:
None
Results First Post Date:
2024-08-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-08-05
Last Update Post Date Type:
ACTUAL